In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions

Hongling Huang(Xiamen University), Hongbo Chi(St. Jude Children's Research Hospital), Lingyun Long(Lanzhou University), Yogesh Dhungana(St. Jude Children's Research Hospital), Chenxi Qian(Wuhan University of Technology), Jana Raynor(St. Jude Children's Research Hospital), Hao Shi(St. Jude Children's Research Hospital), Gustavo Palacios(Icahn School of Medicine at Mount Sinai), Jun Wei(Jilin Medical University), Yong‐Dong Wang(St. Jude Children's Research Hospital), Peipei Zhou(St. Jude Children's Research Hospital), Jiyang Yu(Columbia University Irving Medical Center), Guotong Fu(Nanchang University), Jordy Saravia(St. Jude Children's Research Hospital), Shaofeng Liu(St. Jude Children's Research Hospital), Nicole M. Chapman(St. Jude Children's Research Hospital)
Cell
February 25, 2021
10.1016/j.cell.2021.02.021
Cited by 153

Related Papers

HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996
Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis
|Nature Immunology|2016|487
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
|Nature|2019|445
Lipid signalling enforces functional specialization of Treg cells in tumours
|Nature|2021|422